COVID-19: Find the update to the JobKeeper Payment announced this morning and other support for business on our coronavirus page. If your business is based in Victoria, you can find information about business restrictions on Business Victoria’s website. ×
The request video could not be loaded at this time. Please try again later.

Vaxxas

Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.

The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.


Angus Foster, Chief Development and Operations Manager, Vaxxas

Company Profile

Company: Vaxxas Pty Ltd

Sector: Biotechnology

Location: Brisbane

Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.

For more information, visit Vaxxas's website.